Customs amendment expands exempted drug intermediates and inputs, adding specified chemical precursors for pharmaceutical manufacture. The Central Government, invoking section 25 of the Customs Act, amends an existing customs exemption notification by substituting a tariff heading reference and inserting and substituting multiple serial entries in the notification table. The amendments add specific chemical precursors, reagents and intermediates linked to the manufacture of named pharmaceuticals, thereby expanding and specifying which inputs qualify for the customs exemption for drug intermediates and related materials.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Customs amendment expands exempted drug intermediates and inputs, adding specified chemical precursors for pharmaceutical manufacture.
The Central Government, invoking section 25 of the Customs Act, amends an existing customs exemption notification by substituting a tariff heading reference and inserting and substituting multiple serial entries in the notification table. The amendments add specific chemical precursors, reagents and intermediates linked to the manufacture of named pharmaceuticals, thereby expanding and specifying which inputs qualify for the customs exemption for drug intermediates and related materials.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
